激智科技(300566.SZ):2020年限制性股票激勵計劃首次授予部分第一個歸屬期可歸屬為136.71萬股
格隆匯9月8日丨激智科技(300566.SZ)公佈,此次符合歸屬條件的激勵對象共計89人;
歸屬期可歸屬股數:2020年限制性股票激勵計劃首次授予部分第一個歸屬期可歸屬數量為136.71萬股,佔目前公司總股本232,800,750股的0.59%;
歸屬股票來源:公司向激勵對象定向發行公司A股普通股股票;
此次歸屬的限制性股票待相關手續辦理完成後,公司將發佈相關上市流通的公吿,敬請投資者關注。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.